BAY 2927088 (Sevabertinib)
Product Specifications
CAS Number
2521285-05-0
Synonyms
Sevabertinib
Target
Others
Applications
Others
Molecular Formula
C24H25ClN4O5
Additionnal Information
BAY 2927088 (Sevabertinib) is the first non-covalent, potent, oral, selective, and reversible inhibitor of tyrosine kinase that potently inhibits mutant HER2 and mutant EGFR in preclinical models. It targets Exon 20 insertions in non-small-cell lung carcinoma (NSCLC) patients.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC881037-500 1x 500 µL
CD44 Standard (DF1485), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC682810-100 1x 100 µL
CELA3B / ELA3B (Pancreatic Function Marker) (CELA3B/2810R), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681101-500 1x 500 µL
MCAM / MUC18 / Mucin 18 / CD146 (MCAM/1101), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC881868-500 1x 500 µL
Glycophorin A / CD235a (Erythrocyte Marker) (rGYPA/280), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details